Shanghai Acebright Pharmaceuticals Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Acebright Pharmaceuticals Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Pharmacokinetics of Simmiparib in Patients With Malignant Advanced Solid Tumor (NCT02993913) | Shanghai Acebright Pharmaceuticals Co., Ltd. | 2016-12-01 |
Track Shanghai Acebright Pharmaceuticals Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.